You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 145 No. 11, November 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (44)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Ten-Year Survival in Multiple Myeloma

Raymond Alexanian, MD

Arch Intern Med. 1985;145(11):2073-2074.


Abstract

• Of 305 consecutive patients with symptomatic multiple myeloma treated between 1965 and 1974, a total of 4% survived ten years. Virtually all were less than 65 years old, presented with low or intermediate stage disease, and responded well to chemotherapy. Prolonged unmaintained remissions, slow tumor growth, and recontrol of relapsing disease were common. Acute leukemia caused the death of two of six long-term survivors. Patients treated since 1974 lived longer than those seen previously, a finding attributed to better control of complications and more effective combination chemotherapy.

(Arch Intern Med 1985;145:2073-2074)



Author Affiliations

From The University of Texas M. D. Anderson Hospital and Tumor Institute, Houston.


Footnotes

Accepted for publication Feb 18, 1985.

Reprint requests to Department of Hematology (Box 1), M. D. Anderson Hospital and Tumor Institute, 6723 Bertner Ave, Houston, TX 77030 (Dr Alexanian).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Early Mortality After Diagnosis of Multiple Myeloma: Analysis of Patients Entered Onto the United Kingdom Medical Research Council Trials Between 1980 and 2002--Medical Research Council Adult Leukaemia Working Party
Augustson et al.
JCO 2005;23:9219-9226.
ABSTRACT | FULL TEXT  

High-dose therapy intensification compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy: long-term results from a prospective randomized trial from the Spanish cooperative group PETHEMA
Blade et al.
Blood 2005;106:3755-3759.
ABSTRACT | FULL TEXT  

Transplantation for multiple myeloma: who, when, how often?
Blade et al.
Blood 2003;102:3469-3477.
FULL TEXT  

Multiple Myeloma in Patients Younger Than 30 Years: Report of 10 Cases and Review of the Literature
Blade et al.
Arch Intern Med 1996;156:1463-1468.
ABSTRACT  

Renal Failure in Multiple Myeloma
Alexanian et al.
Arch Intern Med 1990;150:1693-1695.
ABSTRACT  

Long-term Survival in Multiple Myeloma
Blade et al.
Arch Intern Med 1986;146:1637-1638.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.